Overdose prevention programs are extremely cost effective, save lives and deliver critical resources and information to people most at risk of experiencing an overdose. While most current overdose prevention efforts focus on opioid overdose, DPA is seeking policy solutions that would help save the lives of people using all types of drugs.
The Drug Policy Alliance is working to pass federal legislation that would monitor overdose trends, support overdose research and allocate much-needed federal funding to states, cities, tribal governments and community-based groups for life-saving overdose prevention programs. Federal aid is urgently needed to make the overdose reversal drug naloxone more widely available. Naloxone (also called Narcan) is an inexpensive, generic drug that works to reverse an opioid overdose by restoring breath to unconscious overdose victims. It has been used with efficacy and safety in emergency rooms and ambulances in the United States for over forty years.
Our overdose prevention work on the state level includes promoting naloxone distribution and 911 Good Samaritan legislation that allows those present when an overdose occurs to call for help without risking criminal punishment for themselves or the person experiencing an overdose.
DPA is also leading the national overdose awareness campaign, Purple Ribbons for Overdose Prevention. This national effort to raise awareness about the urgency of the overdose crisis kicked off with the launch of our Purple Ribbons for Overdose Prevention Facebook Cause. Over 17,000 members from around the world are now sharing information and getting involved in making a difference.